HomeSHTDY • OTCMKTS
add
Sinopharm Group ADR
Previous close
$12.21
Day range
$12.21 - $12.23
Year range
$10.54 - $15.26
Market cap
59.76B HKD
Avg Volume
24.18K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 144.38B | -2.09% |
Operating expense | 6.36B | -6.80% |
Net income | 2.00B | -12.11% |
Net profit margin | 1.39 | -9.74% |
Earnings per share | — | — |
EBITDA | 5.65B | -6.41% |
Effective tax rate | 27.77% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 47.16B | 8.83% |
Total assets | 420.17B | -2.19% |
Total liabilities | 290.70B | -5.36% |
Total equity | 129.47B | — |
Shares outstanding | 3.12B | — |
Price to book | 0.47 | — |
Return on assets | 2.71% | — |
Return on capital | 5.26% | — |
Cash Flow
Net change in cash
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 2.00B | -12.11% |
Cash from operations | 164.40M | -97.47% |
Cash from investing | -1.15B | 11.27% |
Cash from financing | 2.70B | 548.42% |
Net change in cash | 1.71B | -62.83% |
Free cash flow | -9.01B | — |
About
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Founded
2003
Website
Employees
100,251
